Skip to main content

This website contains promotional content and is intended for Healthcare Professionals

Watch the video and get to know more on Alpheus trial. Since Percutaneous coronary intervention (PCI)-related myonecrosis is frequent and can affect the long-term prognosis of patients, then stronger platelet inhibition could potentially lower these events and make the PCI procedure safer.

MAT-BH-2200189/v2/Jun 2023